Featured
Last news
History beckons as cardinals gather to elect new pope
Cardinals from across the world will be shut into the Sistine Chapel on Wednesday for a secretive conclave to elect the next head of the world's 1.4 billion Catholics.
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.The collaboration continues a successful partnership on evaluating new treatment regimens aimed at reducing treatment duration and overcoming resistance to current therapies.
The Barber Shop Marketing Wins National Recognition for Creative Excellence and Strategic Campaigns
Leading North Texas Advertising Agency Represented City of Richardson and Town of Addison
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Reports Net Revenues of $170.5 Million for the Three Months Ended March 31, 2025
Aster Guardians Global Nursing Award Unveils Top 10 Finalists for 2025 from 100,000+ Registrations
Over 100,000 registrations received from nurses across 199* countries - a 28% increase from the third edition, which received 78,000+ registrations.One of the shortlisted Top 10 finalists will be honoured with the grand title award and a prize of USD 250,000.These finalists were selected following a rigorous evaluation process, led by esteemed expert jury and grand jury panels. The entire process is independently moderated by the appointed "Process Advisors" Ernst & Young LLP.
Envela Reports First Quarter 2025 Financial Results
IRVING, TX / ACCESS Newswire / May 7, 2025 / Envela Corporation today announced its financial results for its first quarter ended March 31, 2025. The Company reported quarterly revenue of $48.3 million and quarterly earnings per diluted share of $0.10.
Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025
DENVER, CO / ACCESS Newswire / May 7, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its third quarter of fiscal 2025, after the market close on Wednesday, May 14, 2025. The Company has scheduled a conference call and webcast that same day, Wednesday, May 14, 2025, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.
Telomir Pharmaceuticals Demonstrates Telomir-1 Reverses Key Drivers of Cellular Decline in Human Cell Lines Supporting Therapeutic Potential in Autism and Spasmodic Dysphonia
MIAMI, FLORIDA / ACCESS Newswire / May 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), a leader in age-reversal science, today announced new preclinical data showing that its lead oral drug candidate, Telomir-1, reverses multiple hallmarks of cellular decline across several human cell lines. The findings include improved mitochondrial activity, reduced oxidative stress, restored calcium balance, and protection from toxic metal effects-offering a mechanistic foundation for the Company's new research initiatives in autism spectrum disorder (ASD) and spasmodic dysphonia (SD).
TRIANA Biomedicines Announces the Appointment of Caroline Germa as Chief Medical Officer and Attracts Leading Drug Discovery and Development Expert to its Scientific Advisory Board
CMO appointment strengthens the leadership team in preparation for advancement of the first product into the clinicDr. Robert Abraham appointed as Scientific Advisory Board Chair
ConEquip Kicks Off Season 5 of "America's Hardest Worker" with $6,000 in Cash Prizes and a Honda Side-by-Side Grand Prize
Recognizing dedication across America's workforce with meaningful prizes and powerful stories
CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement
BEIJING, CHINA / ACCESS Newswire / May 7, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") dated May 5, 2025 stating that the Company is not in compliance with the requirement to maintain a minimum Market Value of Listed Securities ("MVLS") of $35 million as set forth under Nasdaq Listing Rule for continued listing on The Nasdaq Capital Market.
AcutePet Urgent Care Opens in Summerville, SC - Bringing Affordable Emergency-Level Care to Local Pet Owners
New location offers extended hours and same-day urgent care for pets-seven days a week.
Announcing the Inaugural Recipient of the Steve Fairfield Memorial Award for Flexible Packaging Innovation
Steve Gosling of Cheer Pack North America Named First Recipient of Annual Award
Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab
Ludwig Enterprises, Inc. (OTC:LUDG), previews its first in a pipeline of non-invasive cancer screening tests powered by mRNA biomarker analysis.
Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts
Crofelemer is the only oral drug approved by the FDA's Center for Drug Evaluation and Research under Botanical GuidanceClick here to access replay of company's April 30, 2025 investor webcast
Dolphin Clients Shine at the 2025 Met Gala
MIAMI, FL / ACCESS Newswire / May 7, 2025 / Once again, Dolphin (NASDAQ:DLPN) clients and partners were front and center at one of the year's most iconic cultural moments. From the Academy Awards to the Grammys, Fashion Week to the Super Bowl, and across major music and food festivals, Dolphin's influence is felt wherever pop culture is made - including the 2025 Met Gala.
DirectTrust(R) Announces Appointment of Two New Board Members
Ryan Howells and Ryan Smith bring extensive expertise in digital health innovation and interoperability
Interactive Strength Inc. (Nasdaq:TRNR) Provides Shareholder Update on Sportstech's Strong April 2025 and LTM Performance
Sportstech Announced Strong Results, with April 2025 revenue growth at 36% YOYCurrent FX rates indicate that the LTM figures would be approximately $54M in Revenue and $5M in EBITDA through April 2025Strong Business Momentum, Revenue and Positive EBITDA Underscore Target's Operational Strength and Logic of Acquisition in advance of Closing
Organic Produce Summit Announces Dynamic Industry Education Sessions
MONTEREY, CA / ACCESS Newswire / May 7, 2025 / Organic Produce Summit today unveils premier lineup of keynote sessions and educational panels that will bring together industry leaders to explore the latest trends and innovations in organic produce. The event will take place July 9-10, 2025, in Monterey, CA.
Inside Self-Storage World Expo Delivers Comprehensive Industry Insights and New Show Features
LAS VEGAS, NV / ACCESS Newswire / May 7, 2025 / Inside Self-Storage (ISS) World Expo, the self-storage industry's largest annual conference and tradeshow, engaged the community with four days of conference programming and two days of exhibits, April 22-25, driving advancement in facility development, investment, operation and much more.
Motown legend Smokey Robinson sued for sexual assault
Motown legend Smokey Robinson was facing a multimillion dollar lawsuit on Tuesday from four former housekeepers who allege the soul singer repeatedly raped and sexually assaulted them.
Israel's plan for Gaza draws international criticism
Israel drew international condemnation on Tuesday over its plans for an expanded Gaza offensive, as the country's far-right finance minister called for the Palestinian territory to be "destroyed".
Top US court allows Trump's ban on trans troops to take effect
A divided US Supreme Court on Tuesday allowed President Donald Trump's ban on transgender military personnel to take effect while litigation proceeds, putting thousands of troops at risk of dismissal.
Sudan cuts ties with UAE, accused of backing paramilitaries
Sudan's army-aligned government on Tuesday severed diplomatic ties with the United Arab Emirates, accusing the Gulf state of supplying weapons used by the rival paramilitaries to strike its de facto capital.
'Wagatha Christie': Vardy and Rooney settle on legal costs
The years-long libel battle between England footballer wife Rebekah Vardy and Coleen Rooney drew to a close on Tuesday with a specialist UK court ordering Vardy to pay some £1.4 million to her rival.
Move over Met Ball. For fashion wow head to the Vatican
Forget feathers, fringe and sparkles. But if bold and brash colour is your thing, look no further than the conclave at the Vatican.
Cardinals to move into Vatican on eve of conclave
Cardinals will on Tuesday begin moving into the Vatican accommodation where they will stay during the conclave, on the eve of their historic, secretive meeting to elect a new pope.
How a privately owned city in Kenya took on corrupt officials
To many, Tatu City on the outskirts of Nairobi looks like a success.
Australian mushroom murder suspect rejected help preparing meal: witness
An Australian woman accused of murdering three people with a toxic mushroom-laced lunch rejected offers of help before serving the dish, the sole guest to survive the deadly meal told a court on Tuesday.
Prayers, pride in Philippine papal contender's hometown
Philippine Cardinal Luis Antonio Tagle may be one of the favourites to be named the next pope, but a Catholic Sister who has known him for half a century says she will never pray for it to happen.
Boditech Med and SphingoTec Announce Launch of AFIAS penKid(R) Assay for Kidney Function Diagnostics
Boditech Med and SphingoTec announce the launch of the AFIAS sphingotest® penKid® assay, a diagnostic tool designed to aid in kidney function assessment for critically ill patients.The IVDR-marked assay provides quantitative measurements of Proenkephalin A 119-159 (penKid), supporting clinical decision-making in acute and critical care.This launch follows a licensing agreement granting Boditech the rights to develop and commercialize penKid-based assays, as well as a market development agreement between the two companies.
The Dixie Group 2025 Q1 Earnings Release and Conference Call
DALTON, GA / ACCESS Newswire / May 6, 2025 / You are invited to participate in a conference call with the management of THE DIXIE GROUP, INC (OTCQB:DXYN) regarding results for 2025 First Quarter Earnings Release on Friday, May 9, 2025, at 10:00 a.m. Eastern Time.